What We Do
MTRC has been providing reimbursement, health economic and evidence synthesis services to the medical device and in-vitro diagnostics industry in Europe since 2017.
Coding, payment mechanism, reimbursement tariffs, policy and HTA considerations
Pathways to establish reimbursement, funding and obtain endorsement in the HTA programs
Strategic analysis of the sufficiency of evidence to obtain reimbursement and HTA approval in Europe and recommendations about evidence generation
Concise document to outline value proposition and evidence situation for medical technology
Service of monitoring key reimbursement and HTA developments for medical devices, in-vitro diagnostic tests, and digital technologies in Europe and globally
News and insights
To stay up to date, we constantly monitor developments of reimbursement systems in Europe
Subscribe to our newsletter to get bi-weekly updates key reimbursement/HTA news items
Our free newsletter contains less than 10% of the identified news items. Access our paid service Market Access Monitor to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).
Geography of our projects
MTRC is a provider of multi-country European projects. We have worked on the projects in 34 European countries
MTRC in numbers
An extremely specialised boutique consultancy with a global impact
Technological coverage of our services
We provide services for major types of medical technologies:
Our team has worked on hundreds of reimbursement/HEOR projects within different clinical and technological areas, including heart valve replacement, minimally invasive and open heart surgery, coronary, cerebral and peripheral stenting, coronary diagnostic and imaging techniques (fractional flow reserve, intravascular ultrasound), coronary, cerebral and peripheral vascular thrombectomy, implantable and extracorporeal ventricular assist devices, clinic- and home-based dialysis, extracorporeal membrane oxygenation, apheresis, obesity surgery, hernia and reconstruction surgery, tissue products and skin reconstruction surgery, negative wound pressure therapy and medical bandages, neurostimulators for different indications, cell therapy, rehabilitation devices, devices for minimally invasive and open spine surgery, embolization procedures, glucose monitoring, use of fusidial markers, radiotherapy, and endoscopy, amongst others.
Market Access Monitor
Service of monitoring key reimbursement and HTA developments for medical devices, in-vitro diagnostic tests, and digital technologies in Europe and globally.
Free EU reimbursement news and Publications Digest
Bi-weekly newsletter with 10 key reimbursement/HTA news items and summaries of the most important peer-reviewed publications. Access news from as far back as 2017.
Analytical White Papers
Free analytical and research White Papers on the topic of reimbursement, HTA and evidence requirements for medical devices and IVD tests in Europe.
Brief summaries of the market access landscape for medical technologies and in-vitro diagnostic tests in European countries.
Report on innovative payment schemes for EU association Med Tech Europe
In 2022 Med Tech Europe and MTRC developed a comprehensive report on innovative payment schemes in European countries.
Educational materials on market access
MTRC offers the most comprehensive repository of training presentations on the topic of med tech market access. We offer both general introductory seminars (including pre-recorded webinars) and more than 70 country-specific seminars.
Youtube channel “Market Access Insider”
In 2019 MTRC launched a channel dedicated to the topic of market access for medical devices. See our interviews with different stakeholders from EU countries.
Get in touch
Contact us to discuss your needs and learn about our services